This is supported by previous studies calling for further investigation of intercellular communication between prominin-1 (CD133+) niches and adjacent blood vessels within GBM, with the view to design specific targeted treatments directed at brain tumor stem cells [53]. The gene discussed is PROM1; the disease is glioblastoma.